You are here

Notices of approved and permitted restricted representations

Therapeutic goods advertisements to consumers must not refer to a serious form of a disease, condition, ailment or defect (as defined in the Therapeutic Goods Advertising Code (the Code) unless authorised by the TGA. These are known as restricted representations.

The TGA can authorise the use of restricted representations by:

  • approving an advertiser to use the representation under section 42DF of the Therapeutic Goods Act 1989 following the successful consideration of an application
  • permitting the use of the representation by any advertiser under section 42DK of the Act.

Certain references, including representations about the treatment and prevention of the most serious forms of diseases and conditions like cancer, are prohibited representations under the Code. Prohibited representations can only be used in advertising where the TGA has expressly permitted the use under section 42DK of the Act.

The written notices of approval or permission for the use of restricted representations, as well as notices of permission to use prohibited representations, can be accessed below.

  • 13 September 2002
    Notice of advertising exemption under Regulation 7C (1) of the Therapeutic Goods Regulations for broad spectrum 30+ sunscreens
  • 30 April 2002
    Notice of advertising exemption under Regulation 7C (1) of the Therapeutic Goods Regulations for metamucil
  • 19 February 2001
    Notice of advertising exemption under Regulation 7C (1) of the Therapeutic Goods Regulations for Panadol

Withdrawn advertising exemptions (Section 42DI)

After the Secretary has granted approval to use a restricted representation in advertising to consumers, there are a number of circumstances under which the Secretary may subsequently withdraw the approval. These circumstances are described within Section 42DI of the Therapeutic Goods Act.